OAKTREE CAPITAL MANAGEMENT LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,054,267
+14.4%
2,111,0000.0%0.02%
+10.0%
Q3 2022$1,796,000
-38.6%
2,111,000
-36.0%
0.02%
-41.2%
Q2 2022$2,927,000
+34.7%
3,300,000
+33.0%
0.03%
+47.8%
Q1 2022$2,173,0002,481,0000.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 128,679,626$110,468,0065.49%
CAMDEN ASSET MANAGEMENT L P /CA 77,223,000$65,160,7672.42%
Penn Mutual Asset Management, LLC 1,555,000$1,312,1091.23%
ZAZOVE ASSOCIATES LLC 9,108,000$7,715,0000.80%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 50,000,000$42,190,0000.67%
Laffer Tengler Investments, Inc. 2,399$2,032,8230.60%
SHENKMAN CAPITAL MANAGEMENT INC 9,019,000$7,767,6720.58%
LINDEN ADVISORS LP 62,930,000$53,329,4250.55%
SSI INVESTMENT MANAGEMENT LLC 4,577,000$3,862,0740.32%
Sonora Investment Management Group, LLC 4,355,000$3,675,0600.31%
View complete list of HALOZYME THERAPEUTICS INC shareholders